NEWS

Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times In … – Nasdaq

2017-09-11 Michael Zand NEWS

Arcadia Biosciences To Accelerate Agricultural Trait Development … – Business Wire (press release)

Arcadia Biosciences To Accelerate Agricultural Trait Development …Business Wire (press release)Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company, announced today that it has signed a global licensing agreement with the.Arca… Continue reading

2017-09-11 Michael Zand NEWS

New treatment gives second chance to leukemia patients at U of Chicago – The Columbia Chronicle

VarsityNew treatment gives second chance to leukemia patients at U of ChicagoThe Columbia ChronicleThe University of Chicago Medical Center is one of the first hospitals to offer a new cancer treatment that is giving late-stage leukemia and lymphoma pa… Continue reading

2017-09-11 Michael Zand NEWS

Immunotherapy Changes First-Line Paradigm in Advanced RCC – Medscape

MedscapeImmunotherapy Changes First-Line Paradigm in Advanced RCCMedscapeNew data are set to change the paradigm for the first-line treatment of advanced renal cell carcinoma (RCC), after a phase 3 trial showed significantly improved overall survival (… Continue reading

2017-09-11 Michael Zand NEWS

Immunotherapy Changes First-Line Paradigm in Advanced RCC – Medscape

2017-09-11 Michael Zand NEWS

Mesothelioma Community Excited About First-Ever Gene Therapy Approval From FDA – MesotheliomaHelp.org (blog)

Mesothelioma Community Excited About First-Ever Gene Therapy Approval From FDAMesotheliomaHelp.org (blog)In July, MesotheliomaHelp reported on the pending approval of two different types of gene therapy for treating cancer and inherited diseases. Last … Continue reading

2017-09-11 Michael Zand NEWS

Early NLR Changes Predict mRCC Immunotherapy Outcomes – Renal and Urology News

Renal and Urology NewsEarly NLR Changes Predict mRCC Immunotherapy OutcomesRenal and Urology NewsRises and decreases in neutrophil-to-lymphocyte ratio at 6 weeks after treatment with anti-PD-1/PD-L1 immune checkpoint blockade is associated with progres… Continue reading

2017-09-11 Michael Zand NEWS

Breakthrough made in stem cells science – Independent Online

Breakthrough made in stem cells scienceIndependent OnlineChicago – Two groups of scientists have successfully transformed human skin cells into stem cells, potentially granting unlimited access to the foundation cells which can replace diseased or dama… Continue reading

2017-09-11 Michael Zand NEWS

1
…
1,221
1,222
1,223
1,224
1,225
…
3,595

Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times In …
Nasdaq
PLYMOUTH MEETING, Pa., Sept. 11, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (NASDAQ:INO), today announced that an interim data analysis showed that its INO-5150 cancer immunotherapy product generated antigen-specific CD8+ killer …

and more »

Login

Cart

Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times In … – Nasdaq

Arcadia Biosciences To Accelerate Agricultural Trait Development … – Business Wire (press release)

New treatment gives second chance to leukemia patients at U of Chicago – The Columbia Chronicle

Immunotherapy Changes First-Line Paradigm in Advanced RCC – Medscape

Immunotherapy Changes First-Line Paradigm in Advanced RCC – Medscape

Mesothelioma Community Excited About First-Ever Gene Therapy Approval From FDA – MesotheliomaHelp.org (blog)

Early NLR Changes Predict mRCC Immunotherapy Outcomes – Renal and Urology News

Breakthrough made in stem cells science – Independent Online

Recent Posts

Blog Categories

Blog Categories

Blog Categories

Blog Categories

Blog Categories